key: cord-0720038-iqlfvnx0
authors: Glen, P.; Aurora, F.; Thomas, S.; Kissun, D.
title: Orthognathic surgery in Covid-19 times, is it safe?
date: 2021-01-22
journal: Br J Oral Maxillofac Surg
DOI: 10.1016/j.bjoms.2021.01.005
sha: afc4ffdec2f1416daef89d02535e5392cdc8108b
doc_id: 720038
cord_uid: iqlfvnx0

INTRODUCTION: Covid-19 has impacted the provision of orthognathic surgery globally. Uncertainty around its effects and transmission in aerosol generating procedures (AGP’s) has led to disagreement within maxillofacial surgeons into the safety of orthognathic surgery during the pandemic. We present a local case series of orthognathic surgery undertaken during the Covid-19 pandemic. To our knowledge no such similar study has been reported worldwide. MATERIALS AND METHODS: Data was collected from the 1(st) June to 30(th) November 2020 for all patients undergoing orthognathic surgery by a single consultant. All procedures and inpatient stays were performed ‘off site’ at the local Spire Healthcare Group plc© facility. A strict pre-operative 2-week self-isolation period and negative Covid-19 testing was mandatory. All procedures were classified as AGP’s and personal protective equipment (PPE) was worn in line with local guidelines. The primary outcome was 30-day Covid-19 infection among patients, with day 0 the date of surgery. Secondary outcome measures included duration of stay, return to theatre and complications. RESULTS: 59 patients were identified. 42/59 had bimaxillary procedures and 17/59 single jaw. 9/17 had maxillary and 8/17 had mandibular procedures. 3/59 had simultaneous genioplasty. Median duration of stay was 1 night (range 1-3). Immediate and late complications were seen in 3% (2/59) and 3% (2/59) respectively. 1% (1/59) returned to theatre. Zero patients tested positive in the 30-day post-operative period. No staff members tested positive for the duration of the study. CONCLUSION: Adopting strict safety protocols, orthognathic surgery can be safely delivered during the pandemic without detriment to the patient or staff.

The outbreak of Covid-19 has had a profound impact on the delivery of orthognathic services across the United Kingdom (UK). Towards the beginning of the year as the pandemic took a grip across UK hospitals, hospital managers were advised to reduce all nonessential operating in order to increase capacity for anticipated Covid-19 related admissions. This culminated in a letter written by NHS England's chief executive Simon Stevens and NHS chief operating officer Amanda Pritchard on the 17 th March 2020, to all NHS England hospital chief executives', to suspend all non-essential surgery for at least three months from the 15 th April 2020. 1, 2 The purpose of this radical move aimed to free up around 30,000 acute beds to provide essential additional capacity. At the bequest of NHS England at the start of the pandemic, the Federation of Surgical Speciality Associations (FSSA) produced a clinical guideline to help differentiate essential from non-essential conditions. 3 This document comprised of a tiered level of surgical procedures for all surgical specialities, ranging from emergency procedures (priority 1a, <24h) to routine procedure J o u r n a l P r e -p r o o f (priority 4, >3 months). Owing to the elective nature of dentofacial disproportional surgery, all orthognathic surgery was considered priority 4.

As the infection rates slowed health leaders looked at measures to increase routine operations and treatment. This restructuring required careful planning and reorganisation within local NHS teams, ensuring continued safety of staff and patients, whilst limiting the spread of the disease. Regional variation in the available resources along with local infection rates has had a major impact on how this was achieved. Additionally, orthognathic surgery is complicated in its multidisciplinary approach requiring both surgical planning clinics and regular orthodontic face to face follow up. The dental speciality as a whole has been significantly affected by the pandemic, but as advise on aerosol generating procedures (AGP's) and personal protective equipment (PPE) recommendations have become clearer, the reinstating of orthodontic clinics has paved a pathway for the resumption of orthognathic activity.

Nevertheless, the impact of Covid-19 on post-operative recovery has led to disagreement within the speciality as to whether elective orthognathic procedures should be offered.

Patients undergoing orthognathic surgery are at an increased risk of Covid-19 exposure within the hospital setting and may be susceptible to pulmonary complications associated to mechanical ventilation. 4 As part of NHS England's response plan, temporary contracts were negotiated with the independent hospitals to increase capacity. This facilitated operative capacity by using such independent sector units as 'Covid Free Hubs' for elective 'off site' operating.

We present a local case series to review the safety of elective orthognathic surgery following the reintroduction of routine operating during the Covid-19 pandemic.

We describe a case series of all patients undergoing elective orthognathic surgery within a single regional unit, by a single consultant surgeon during the Covid-19 pandemic. Data was collected over a 6 month period from 1 st June 2020 to 30 th November 2020. All operative procedures and inpatient stays were performed 'off site' to the main hub unit and undertaken at the local Spire Healthcare Group plc facility. On site medical cover was provided by the local resident medical officer (RMO). Off site consultant and registrar surgical cover were provided by the operating consultant and the on call maxillofacial registrar. Consultant anaesthetic cover was provided by the anaesthetist performing the list that day.

Patients were identified by the local orthognathic surgical waiting list. Priority was given to the longest waiters. Only patients of American Society of Anaesthesiologists (ASA) grade 1-2 were eligible for surgery. Patients were initially contacted by the booking office to offer a provisional date for surgery and that it would be performed away from the main hospital.

Patients' willing for surgery attended an outpatient clinic at least 2 weeks prior to surgery for planning and consent.

A strict self-isolation policy of 2 weeks prior to surgery was required. Patients failing to comply with self-isolation regulations would have their surgery postponed. A negative Covid-19 test was mandatory 48-72h prior to admission. All staff were required to have No members from the surgical or anaesthetic teams tested positive during routine screening tests. Data regarding the scrub teams and wider nursing staff was not available.

The outbreak of Covid-19 has had a large impact on the delivery of elective surgery internationally. A global expert response study conducted by the COVIDSurg collaborative estimated that 28.4 million operations worldwide would be cancelled or postponed during the peak 12 weeks of disruption due to Covid-19, most of which would be for benign conditions (approximately 90%). Within the UK alone, over half a million operations were cancelled over the peak 12 weeks with the vast majority (93%, 480000/516000) being noncancer related cases. 5 The risks of post-operative complications related to Covid-19 are not completely understood. The COVIDSurg collaborative also undertook a single large, international, multicentre cohort study (1,128 patients, 235 hospitals in 24 countries) to measure postoperative mortality and pulmonary complications in patients undergoing surgery with Covid-19 infection. They reported an overall increased 30-day mortality of 23.8% in patients undergoing surgery who had Covid-19 infection confirmed within 7 days before or 30 days J o u r n a l P r e -p r o o f after surgery. Important factors found to be associated with an increased mortality included male sex, over the age of 70 years and poorer ASA grade (3) (4) . 6 In addition to this, a study An important factor to note from the COVIDSurg collaborative was that mortality significantly affected the older population with poorer ASA grades. Orthognathic patients are typically younger in their late teens and twenties and represent a healthy and well motivated cohort of patients. As of the 29 th November 2020, only 0.06% (23/40,405) and 0.8% (276/33,637) of the 0-19 and 20-39 year age groups respectively had died in hospitals in England Wales after testing positive for Covid-19. 9 Although it is not possible to comment whether these patients had underlying comorbidities or the cause of death, the low all cause mortality helps suggests patients aged 0 to 39 years are at low risk dying in hospital with Covid-19.

Regional variation has been an interesting development in the spread of Covid -19. The south west of England on the whole has been considerably less affected than other parts of the UK. We would expect that the risk of viral transmission in regions with a lower prevalence of Covid-19, is lower and arguably safer to undertake surgery than regions with a higher prevalence. Whether this can be proven is questionable though. The UK endured a second wave between the months of October and November 2020 again with regional differences in infection rates. At this time Bristol had a significantl y high daily infection rate (figure 1). The peak Bristol incidence in this wave was recorded on the 8 th November 2020.

The positive Covid-19 test rate per 100,000 population in a 7 day period was 505.2, more than double to the national average of 239.6 on the same date. 10 These figures demonstrate J o u r n a l P r e -p r o o f that the case series was safely performed at time when local infections rates were rising, and a high prevalence of disease should not act as a deterrent when offering orthognathic surgery.

The UK has recently commenced a National mass vaccination programme, however at the same time, a more virulent strain of the virus has become abundantly prevalent within the general population. Furthermore, questions over the availability of the vaccine and the ability to deliver en masse have been raised. It is likely to be many months until we see the effects of this treatment and until then, the risk of Covid-19 is likely to remain within the general population for some time.

This study demonstrates that with strict preoperative isolating, preadmission and regular staff viral PCR testing, orthognathic surgery can be performed in a safe environment without detriment to the patient or staff. Nevertheless, it is fundamental to provide comprehensive information and reasonable risk to the patient as part of the informed consent process. There are increased risks of post-operative complications when undergoing surgery following a positive Covid-19 swab preoperatively, and such patients should have their surgery delayed for at least 4 weeks following a positive test whilst research is ongoing. 7 The authors believe that orthognathic surgery is safe within the typical, young, ASA 1-2 orthognathic population group when strict protocols described are applied.

Ethics approval was not required as there was no variation in treatment and data was collected observationally. No patient information or identifiable information is disclosed.

Not required as no patient identifying information is reported.

The authors declare none.

Covid-19: all non-urgent elective surgery is suspended for at least three months in England

Letter to chief executives of all NHS trusts and foundation trusts, CCG accountable officers, GP practices and primary care networks, and providers of community health services

Clinical Guide to Surgical Prioritisation During the Coronavirus Pandemic

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Elective surgery cancellations due to the COVID-19 pandemic global predictive modelling to inform surgical recovery plans

Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study

Delaying surgery for patients with a previous SARS-CoV-2 infection

Effects of orthognathic surgery on psychological status of patients with jaw deformities

Coronavirus (COVID-19) in the UK, All cases data in Bristol, City of

Daily positive Covid-19 infection rate with 7 day average within the City of Bristol over the study period, 1 st

The authors are both exceptionally grateful and thankful to the Spire Healthcare Group plc for their kind, unwavering support and accommodation during these hitherto untested and exceptional times.